SEARCH FOR DRUG/DEVICE INFORMATION

Call 312-883-1671
 

TRU-RX KEEPS YOU INFORMED ON DRUG/MEDICAL DEVICE NEWS

 

OTHER RECENT NEWS


New Generation Anticoagulants: Profits Over Patients? New Generation Anticoagulants: Profits Over Patients?

May 21, 2015

Amid a blitz of advertising, patients and their physicians are left to weigh the pros and the cons of the blood thinners currently on the market, taking into consideration cost, convenience, and safety.  Xarelto lawsuits continue to mount leading patients to consider how safe this new generation anticoagulant is.  

Read Full ArticlePUBLISHER/WRITER: The Legal Examiner Chicago

 

Low T Lawsuits Number More than 1,300 Low T Lawsuits Number More than 1,300

May 21, 2015

The FDA approved the use of testosterone replacement products only for men who don’t produce enough testosterone because of a medical condition called hypogonadism.  According to testosterone treatment lawyers, the lawsuits allege that the drug companies took their marketing way beyond that.

Read Full ArticlePUBLISHER/WRITER: The Legal Examiner Chicago

 

FDA panel recommends new safety information on AstraZeneca's Onglaza FDA panel recommends new safety information on AstraZeneca’s Onglaza

May 12, 2015

AstraZeneca Plc’s diabetes drug Onglyza has a broadly acceptable cardiovascular safety profile but its label should include new information about the risk of heart failure, a U.S. Food and Drug Administration advisory panel concluded on Tuesday.

Read Full ArticlePUBLISHER/WRITER: Fox News